Newsroom

Sorted by: Latest

-

SkyDrive Signs Australia’s First eVTOL Agreement with Gold Coast Helitours

TOYOTA, Japan--(BUSINESS WIRE)--SkyDrive Inc. (“SkyDrive”), a leading compact eVTOL (*1) aircraft manufacturer based in Japan, today announced the signing of a Letter of Intent (LOI) with Gold Coast Helitours, a premier helicopter operator based in the Gold Coast, Australia. This milestone agreement represents SkyDrive's first LOI with an Australian operator regarding the introduction of its aircraft. The parties have reached a basic agreement on the terms for purchasing up to five "SKYDRIVE" e...
-

Samenvatting: Nanochon krijgt goedkeuring van het Ministerie van Volksgezondheid van Panama om de eerste klinische studie bij mensen met Chondrograft™ te starten

WASHINGTON--(BUSINESS WIRE)--Nanochon, een bedrijf dat medische hulpmiddelen ontwikkelt en Chondrograft™ op de markt brengt, een nieuw, gepatenteerd implantaat voor de behandeling van defecten in het gewrichtskraakbeen van de knie, heeft vandaag bekendgemaakt dat het van het Ministerie van Volksgezondheid van Panama toestemming heeft gekregen om in Panama een klinische First-in-Human (FIH)-studie te starten. Het onderzoek evalueert de veiligheid en de werkzaamheid van Chondrograft™ bij patiënte...
-

Resumen: Nanochon obtiene la aprobación regulatoria del Ministerio de Salud de Panamá para iniciar el primer estudio clínico en humanos de Chondrograft™

WASHINGTON--(BUSINESS WIRE)--Nanochon, empresa de dispositivos médicos que desarrolla Chondrograft™, un innovador implante patentado para tratar lesiones del cartílago articular de la rodilla, anunció hoy que ha obtenido la aprobación del Ministerio de Salud de Panamá para iniciar en el país su primer estudio clínico en humanos (FIH). El estudio evaluará la seguridad y el funcionamiento de Chondrograft™ en pacientes con lesiones focales del cartílago de la rodilla y supone un importante hito en...
-

Nanochon reçoit l’approbation réglementaire du ministère de la Santé du Panama pour lancer la première étude clinique chez l’Homme de Chondrograft™

WASHINGTON--(BUSINESS WIRE)--Nanochon, une société de dispositifs médicaux développant Chondrograft™, un nouvel implant breveté pour le traitement des lésions du cartilage articulaire du genou, a annoncé aujourd'hui avoir reçu l'autorisation réglementaire du ministère de la Santé du Panama pour lancer sa première étude clinique chez l'Homme (FIH) au Panama. L’étude évaluera la sécurité et les performances de Chondrograft™ chez les patients présentant des lésions chondrales focales du genou, ce...
-

Nanochon erhält vom panamaischen Gesundheitsministerium die behördliche Genehmigung zur Einleitung der ersten klinischen Studie am Menschen mit Chondrograft™

WASHINGTON--(BUSINESS WIRE)--Nanochon, ein Medizintechnikunternehmen, das Chondrograft™ entwickelt – ein neuartiges, patentiertes Implantat zur Behandlung von Gelenkknorpeldefekten im Knie –, gab heute bekannt, dass es vom Gesundheitsministerium von Panama die behördliche Genehmigung erhalten hat, seine klinische „First-in-Human“-Studie (FIH) in Panama zu beginnen. Die Studie wird die Sicherheit und Wirksamkeit von Chondrograft™ bei Patienten mit fokalen Knorpeldefekten im Knie untersuchen und...
-

Riassunto: Nanochon riceve l'approvazione dal Ministero della Salute di Panama per avviare il primo studio clinico di Chondrograft™ sull'uomo

WASHINGTON--(BUSINESS WIRE)--Nanochon, azienda produttrice di dispositivi medici che ha sviluppato Chondrograft™, un nuovo impianto brevettato per il trattamento dei difetti della cartilagine articolare del ginocchio, oggi ha annunciato di aver ricevuto un'approvazione normativa da parte del Ministero della Salute di Panama per avviare il suo studio clinico First-in-Human (FIH) a Panama. Lo studio valuterà la sicurezza e le prestazioni di Chondrograft™ nei pazienti con difetti condrali focali d...
-

GMO GlobalSign Expands TLS Connect by GMO Availability, Bringing CLM Automation to Small and Medium Enterprises in APAC and the Middle East

SINGAPORE--(BUSINESS WIRE)--TLS Connect gives SMEs in Asia-Pacific and Middle East markets a lightweight automation tool to simplify TLS certificate management....
-

CesiumAstro Acquires Jariet Technologies to Advance Vertically Integrated Communications and ISR from Silicon to Missions

AUSTIN, Texas--(BUSINESS WIRE)--CesiumAstro Inc., a global leader in advanced space communications and intelligence, surveillance, and reconnaissance (ISR) systems, has announced the acquisition of Jariet Technologies, a leading mmWave RF System-on-Chip (RF-SoC) semiconductor company specializing in leading integrated solutions for SATCOM, electronic warfare (EW), and radar systems. This advances CesiumAstro’s strategy to build the industry's most vertically integrated satellite communications...
-

Voice AI Infrastructure Leader Deepgram to Establish APAC Headquarters in Singapore Following Strategic Investment from EDBI

SINGAPORE--(BUSINESS WIRE)--Deepgram, the real-time AI infrastructure company underpinning the Voice AI economy, announced plans to establish its Asia-Pacific headquarters in Singapore, deepening its commitment to a region where the company is already seeing strong demand for production-grade Voice AI. Deepgram has appointed Sriram Ved as Vice President and General Manager for APAC who will lead the company’s regional strategy and oversee its customer, partner, and go-to-market expansion. Deepg...
-

Grant & Eisenhofer Files Class Action Lawsuit Against Intuit Inc., Extending Class Period of Previously Filed Action

NEW YORK--(BUSINESS WIRE)--Today, Grant & Eisenhofer P.A. filed a class action lawsuit on behalf of Kenneth Bruce against Intuit Inc. (“Intuit” or the “Company”), Intuit’s CEO Sasan K. Goodarzi, and Intuit’s CFO Sandeep S. Aujla (collectively, the “Defendants”). The action alleges that Defendants defrauded investors by making materially false and/or misleading statements and failing to disclose material adverse facts regarding the competitive threat that generative artificial intelligence (...